PharmaCyte Biotech Inc (PMCB)

[markiff]

Realistically, based on the interview what sort of time frame does anyone see on IND at this point? I have the impression that we are looking at a minimum of three or four months and perhaps going into 2018. And I think that is why there is this decline in share cost. Investors, sometimes want to see some results out of an investment. If we are talking about 6 months of complicated processes this would be a red flag for me if I wanted to put more money into this anytime soon. Another thing I have wondered about is why can't trial begin in other countries where it is easier to begin? Why is everything contingent on USA FDA?